ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Hampshire » Internal Medicine

Top Internal Medicine Prescribers in New Hampshire

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KATHLEEN ZAFFINO MD

Internal Medicine

193

$3,195

111
33 are 65+

51%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 24%

$17
Average prescription price

Avg: $64

CHRISTOPHER KIRBY MD

Internal Medicine

214

$24.4K

21
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

95%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

95%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $64

MELKON HACOBIAN M.D.

Internal Medicine

291

$29.2K

65
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $64

MARTHA REGAN-SMITH M.D.

Internal Medicine

311

$9,000

35
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 24%

$29
Average prescription price

Avg: $64

MANDEEP SINGH M.D.

Internal Medicine

441

$20.6K

128
91 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $64

BRIAN HYETT M.D.

Internal Medicine

488

$115K

146
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 24%

$236
Average prescription price

Avg: $64

MARGARET FLYNN MD

Internal Medicine

653

$73.9K

83
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 24%

$113
Average prescription price

Avg: $64

LINDA SINGER MD

Internal Medicine

668

$32.5K

131
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $64

MEENAKSHI GARG

Internal Medicine

697

$32K

65
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $64

ROBERT CHEHADE M.D.

Internal Medicine

738

$77.8K

231
170 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $64

LUKASZ BIERNAT M.D.

Internal Medicine

771

$41.5K

134
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $64

SADIA ASHRAF MD

Internal Medicine

808

$26.3K

156
81 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$33
Average prescription price

Avg: $64

AJAY NANAVATI MD

Internal Medicine

821

$62.4K

98
29 are 65+

35%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $64

BHUPESH KHADKA

Internal Medicine

830

$41.3K

265
168 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $64

KASRA DJALAYER MD

Internal Medicine

877

$49.7K

75
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $64

TIMOTHY LOUGHRAN MD

Internal Medicine

893

$48.8K

205
168 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $64

GREGG MEYER M.D.

Internal Medicine

897

$87.1K

55
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$97
Average prescription price

Avg: $64

JONATHAN ROSS M.D.

Internal Medicine

901

$80.3K

77
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 24%

$89
Average prescription price

Avg: $64

NOBITA CHATTERJEE M.D.

Internal Medicine

911

$36K

111
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $64

TIMOTHY PIKE DO

Internal Medicine

917

$57K

97
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $64

JONATHAN BRIDGES M.D.

Internal Medicine

1,002

$64.4K

142
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $64

L. JOHN KLUNK MD

Internal Medicine

1,014

$69.5K

74
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $64

LYNN SCHWARTZ M.D.

Internal Medicine

1,042

$95.3K

100
78 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$91
Average prescription price

Avg: $64

PALLAVI GUDDETI M.D.

Internal Medicine

1,066

$202K

161
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 24%

$189
Average prescription price

Avg: $64

MARIA FIGUERAS MD

Internal Medicine

1,097

$60.9K

116
86 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank